Funding for this research was provided by:
Georgia Research Alliance (0051)
Article History
Received: 24 February 2020
Accepted: 11 August 2020
First Online: 24 August 2020
Ethics approval and consent to participate
: Not applicable
: Not applicable
: SLS is a stockholder in ArunA Bio. SLS was a part time employee of ArunA Bio during the study. SLS is an inventor on patent US 8,178,089 and US 7,531,354, method of producing feeder cell–free neuroprogenitor cells, by contacting pluripotent stem cells with bFGF and a differentiation protein and assigned University of Georgia Research Foundation and exclusively licensed by ArunA Bio. SLS has a patent pending on neural exosomes, assigned University of Georgia Research Foundation, and exclusively licensed by ArunA Bio. The remaining authors declare that they have no competing interests.